{
       "Malaria": [{
        "Name": "<i>P. falciparum uncomplicated</i>",
        "Details":"Uncomplicated malria and able to retain tablets. <br> <b>Admit Medically</b><br>",
        "Treatment":"1. &nbsp;&nbsp;&nbsp;<b>Quinine</b> sulphate 600mg tds po x 7 days <b>Plus Doxycycline</b> 100mg bd po x 7 days (or <b>Clindamycin</b> 20mg/kg i 3 dividing doses po x 7 days)<br><br><span style='text-align:center;font-weight:bold;'>OR</span><br><br>2. &nbsp;&nbsp;&nbsp; <b>Proguanil-Atovaquone (Malarone)</b> 100mg/250mg : 4 tablets od po x 3 days<br><br><span style='text-align:center;font-weight:bold;'>OR</span><br><br>3. &nbsp;&nbsp;&nbsp; <b>Artemether-Lumefantrine (Riamet or Coartem)</b>- 20mg/120mg: 4 tablets at 0h, 8h, 24h, 36h, 48h, 60h"
      }, {

        "Name": "<i>P. falciparum severe</i>",
        "Details":"<b>Admit medically</b><br><br>",
        "Treatment":"• <b>IVQuinine</b> (loadingdose)<b>20mg/kg(uptomax1.4g)</b> (dilutionin0.9%NormalSaline) over 4 hours infusion, followed by maintenance dose <b><u>8 hours after start of loading dose</b></u> with <b>10mg/kg (up to max 700mg)</b> over <b>4 hours infusion, TDS</b> (Loading dose <b>should not be given</b> if patient has taken oral quinine/mefloquine/ quinidine within the preceding 12 hours). <b><i>Contact Consultant Microbiologist if patient unable to take quinine</i></b> <br><br> <b>PLUS</b><br>• &nbsp;&nbsp; Doxycycline 100mg bd po (<b>or Clindamycin 20mg/kg</b> in 3 dividing doses po), if no contraindication <b>*Consult microbiology/pharmacy if oral route not feasible</b><br><br>Switch iv quinine to oral therapy (Quinine sulphate 600mg tds) once patient is able to tolerate oral medication and improving.<br><br> <b>Duration;</b> 7 days"
      }, {

        "Name": "<i>P. vivax Chloroquine-sensitive</i>",
        "Details":"Allow discharge in uncomplicated cases, follow up in 2 weeks",
        "Treatment":"<b>Chloroquine</b> 600mg at 0hr, then 300mg at 6hr, 24hr and 48hr Followed by <b>Primaquine*</b> 15mg od or 30mg od po x 14 days.<br><b>* Essential to Screen for G6PD deficiency</b>"
      }, {
        "Name": "<i>P. vivax Chloroquine-resistant</i>",
        "Details": "Allow discharge in uncomplicated cases, follow up in 2 weeks</b>",
        "Treatment":"1. &nbsp;&nbsp;&nbsp;<b>Quinine Sulphate</b> 600mg tid po x 7 days + Doxycycline 100mg bd po x 7 days<br><br><span style='text-align:center;font-weight:bold;'>OR</span><br><br>2.&nbsp;&nbsp;&nbsp;<b>Proguanil-Atovaquone (Malarone)</b> 100mg/250mg : 4 tablets od po x 3 days<br><br><u>Followed</u> by <b>Primaquine</b>*15mg od or 30mg od po x 14 days AFTER completion of above course<br><b>* Essential to Screen for G6PD deficiency</b>"
      }, {
        "Name": "<i>P. ovale</i>",
        "Details":"<b>Allow discharge in uncomplicated cases, follow up in 2 weeks</b>",
        "Treatment":"<b>Chloroquine</b> 600mg at 0hr, then 300mg at 6hr, 24hr and 48hr Followed by Primaquine* 15mg od or 30mg od po x 14 days.<br><b>*Essential to Screen for G6PD deficiency</b>"
      }, {
        "Name": "<i>P. malariae</i>",
        "Details":"<b><br>Allow discharge in uncomplicated cases, follow up in 2 weeks</b>",
        "Treatment":"<b>Chloroquine</b> 600mg at 0hr, then 300mg at 6hr, 24hr and 48hr"
      }]
}
